Cargando…

Lipidomics of Alzheimer's disease: current status

Alzheimer's disease (AD) is a cognitive disorder with a number of complex neuropathologies, including, but not limited to, neurofibrillary tangles, neuritic plaques, neuronal shrinkage, hypomyelination, neuroinflammation and cholinergic dysfunction. The role of underlying pathological processes...

Descripción completa

Detalles Bibliográficos
Autor principal:	Wood, Paul L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471525/ https://www.ncbi.nlm.nih.gov/pubmed/22293144 http://dx.doi.org/10.1186/alzrt103

Ejemplares similares

Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
por: Chiurchiù, Valerio, et al.
Publicado: (2022)

Overview and Current Status of Alzheimer’s Disease in Bangladesh
por: Rahman, Md. Rashidur, et al.
Publicado: (2017)

Lipidomics in vascular health: current perspectives
por: Kolovou, Genovefa, et al.
Publicado: (2015)

Current Progress in Lipidomics of Marine Invertebrates
por: Imbs, Andrey B., et al.
Publicado: (2021)

Human Milk Lipidomics: Current Techniques and Methodologies
por: George, Alexandra D., et al.
Publicado: (2018)

Lipidomics unveils the complexity of the lipidome in metabolic diseases
por: Lydic, Todd A., et al.
Publicado: (2018)

Failure of current Alzheimer’s disease hypotheses
por: Wood, Paul L.
Publicado: (2023)

Genes associated with Alzheimer’s disease: an overview and current status
por: Giri, Mohan, et al.
Publicado: (2016)

The expanding organelle lipidomes: current knowledge and challenges
por: Sarmento, Maria J., et al.
Publicado: (2023)

Current Status and Challenges of Stem Cell Treatment for Alzheimer’s Disease
por: Pacheco-Herrero, Mar, et al.
Publicado: (2021)

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
por: Wood, Paul L., et al.
Publicado: (2015)

Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future
por: Prins, Niels D, et al.
Publicado: (2013)

Current status and future prospects of stem cell therapy in Alzheimer’s disease
por: Zhang, Fu-Qiang, et al.
Publicado: (2019)

The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer’s Disease
por: Martins, Ian James
Publicado: (2016)

Targeted Lipidomics of Mitochondria in a Cellular Alzheimer’s Disease Model
por: Kurokin, Irina, et al.
Publicado: (2021)

Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes
por: Liu, Yue, et al.
Publicado: (2021)

Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: Application of single cell‐type lipidomics
por: Asante, Isaac, et al.
Publicado: (2022)

Current status on Alzheimer disease molecular genetics: from past, to present, to future
por: Bettens, Karolien, et al.
Publicado: (2010)

Exploring the Lipidome: Current Lipid Extraction Techniques for Mass Spectrometry Analysis
por: Aldana, Julian, et al.
Publicado: (2020)

Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)

Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer’s disease
por: Tiwari, Virendra, et al.
Publicado: (2023)

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
por: Dakterzada, Farida, et al.
Publicado: (2023)

Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease
por: Obis, Elia, et al.
Publicado: (2023)

The Cardiac Lipidome in Models of Cardiovascular Disease
por: Tomczyk, Mateusz M., et al.
Publicado: (2020)

Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease
por: Huynh, Kevin, et al.
Publicado: (2020)

Lipidomics of Glycosphingolipids
por: Farwanah, Hany, et al.
Publicado: (2012)

Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives
por: Tong, Leslie M, et al.
Publicado: (2015)

Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects
por: Chen, Xiaokun, et al.
Publicado: (2023)

Plasma lipidomics of tuberculosis patients: altered phosphatidylcholine remodeling
por: Wood, Paul L, et al.
Publicado: (2017)

Summary of the Current Status of DNA Vaccination for Alzheimer Disease
por: Vicidomini, Caterina, et al.
Publicado: (2023)

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort
por: Barupal, Dinesh Kumar, et al.
Publicado: (2018)

Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles
por: Llano, Daniel A., et al.
Publicado: (2020)

Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease
por: Dakterzada, Farida, et al.
Publicado: (2022)

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer’s disease brains
por: Novotny, Brenna C., et al.
Publicado: (2023)

Lipidomics in non-alcoholic fatty liver disease
por: Kartsoli, Sofia, et al.
Publicado: (2020)

Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease
por: Proitsi, P, et al.
Publicado: (2015)

Lipidome in colorectal cancer
por: Yan, Guifang, et al.
Publicado: (2016)

The Lipidome Fingerprint of Longevity
por: Jové, Mariona, et al.
Publicado: (2020)

A Current Encyclopedia of Bioinformatics Tools, Data Formats and Resources for Mass Spectrometry Lipidomics
por: Hoffmann, Nils, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t85hpcols65gjtrqmlcef1b5a8